Hinge Health (NYSE:HNGE) reported a 47% increase in first-quarter 2026 revenue, reaching $182 million, which surpasses its previous guidance of $171 million to $173 million. The company also raised its full-year revenue outlook to between $798 million and $804 million, up from $732 million to $742 million, motivated by improved member engagement and billing growth.
For the quarter, Hinge Health achieved an operating margin of 25% and free cash flow of $42 million, up from $4 million a year earlier. The company recently launched a Migraine Care program, its first expansion beyond musculoskeletal issues, utilizing an FDA-cleared device and AI technology to assist migraine sufferers, impacting an estimated 2 million lives.
Looking ahead, Hinge Health projects second-quarter revenue between $194 million and $196 million and operating income of $47 million to $49 million. The company has automated more than 95% of clinician hours related to traditional physical therapy, which is expected to support continued margin growth effectively.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
